Overview:A motivated and innovative pharmaceutical professional with deep understanding and hands-on experience of various drug discovery and development processes. Proficient in leading various affair of drug discovery and development organisation- target ideation to drug candidate selection to shaping the molecules throughout the drug development value chain. Aligning the interest of all the internal and external stakeholders to successfully drive the related business opportunity.Leading Early Development division comprising cross functional team of scientists from DMPK, Pharmacology, Toxicology, CMC (API, formulation, analytical), Quality, Regulatory, Business Analytics, Project & portfolio management, etc. Guiding team to advance programs from preclinical to clinical phase across the multiple therapeutic areas, such as oncology, inflammation, metabolic disorder, CNS, etc., and facilitated the submission of many INDs and ANDA applications for NCEs and Generics.Love networking with people of diverse expertise. Having rich experience in leading cross-functional professionals in a cross-culture environment, and managing the scientific portfolio and related business opportunity from preclinical to clinical development. Successfully collaborated with many US/Europe based pharma and biotechs to drive programs from drug discovery to the clinical stage. 12+ of such programs are at different stages of Global Clinical development. Co-authored 25+ research articles in peer reviewed journals. Key Strengths:Crafting business and operation strategy for new drug product; networking & client management; setting differentiation strategy for commercial success of the product; valuation of new opportunities in the field of drug development; fostering team and driving operational excellence.